HSIC
47
-3
HES
45
-2
AME
48
-2
FCX
27
-4
ABBV
42
-2
CMG
45
-2
TRIP
29
3
DE
53
-5
LOW
46
-2
ALLE
53
3
ORLY
50
-2
NFLX
68
6
UAL
56
3
O
31
5
HSY
35
-2
KR
61
-2
NOC
53
6
HOG
36
-3
GOOGL
42
-5
FDX
37
-3
HSIC
47
-3
HES
45
-2
AME
48
-2
FCX
27
-4
ABBV
42
-2
CMG
45
-2
TRIP
29
3
DE
53
-5
LOW
46
-2
ALLE
53
3
ORLY
50
-2
NFLX
68
6
UAL
56
3
O
31
5
HSY
35
-2
KR
61
-2
NOC
53
6
HOG
36
-3
GOOGL
42
-5
FDX
37
-3
Financhill
Back

Alkermes PLC 10K Form

Sell
35

ALKS
Alkermes PLC

Last Price:
$27.22
Seasonality Move:
3.79%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-01 10Q ALKS/Alkermes PLC Quarterly
2023-10-25 10Q ALKS/Alkermes PLC Quarterly
2023-07-26 10Q ALKS/Alkermes PLC Quarterly
2023-04-26 10Q ALKS/Alkermes PLC Quarterly
2022-11-02 10Q ALKS/Alkermes PLC Quarterly
2022-07-27 10Q ALKS/Alkermes PLC Quarterly

Receive ALKS News And Ratings

See the #1 stock for the next 7 days that we like better than ALKS

ALKS Financial Statistics

Sales & Book Value

Annual Sales: $1.6B
Cash Flow: $180.6M
Price / Cash Flow: 11.66
Annual Sales: $9.03
Price / Book: 3.1

Profitability

EPS (TTM): 2.17000
Net Income (TTM): $367.1M
Gross Margin: $1.3B
Return on Equity: 28.24%
Return on Assets: 17.19%

Alkermes PLC Earnings Forecast

Key Alkermes PLC Financial Ratios

  • The Gross Profit Margin over the past 33 years for ALKS is 84.25%.
  • The Selling, General & Administrative Expenses for ALKS have been equal to 41.42% of Gross Profit Margin.
  • The Research & Development expenses have been 15.75% of Revenue.
  • The Interest Expense is 6.15% of Operating Income.
  • The Net Earning history of ALKS is 23.57% of Total Revenues.
  • Per Share Earnings over the last 33 years have been positive in 17 years.

Alkermes PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ALKS
CUSIP: G01767
Website: alkermes.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.04
Quick Ratio: 2.45

Price-to-Earnings

Trailing P/E Ratio: 12.88
Forward P/E Ratio: 15.71

ALKS Technical Analysis vs Fundamental Analysis

Sell
35
Alkermes PLC (ALKS) is a Sell

Is Alkermes PLC a Buy or a Sell?

  • Alkermes PLC stock is rated a Sell
    The current Alkermes PLC [ALKS] share price is $27.94. The Score for ALKS is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.